Jon Cuthbert

Llulemon athletica (NASDAQ:LULU) announced its financial results for the fourth quarter and fiscal year ended February 1, 2026, revealing a tale of two markets.

Expion360 (NASDAQ:XPON) on Tuesday reported full-year 2025 net sales of $9.7 million for the period ended December 31, 2025, an increase of 72% from the prior year, reflecting continued expansion in lithium battery solutions for recreational vehicles, marine and industrial applications.

CervoMed (NASDAQ:CRVO) announced on Tuesday that it has achieved critical regulatory and clinical alignment for the Phase 3 development of neflamapimod, its oral small-molecule treatment for dementia with Lewy bodies (DLB).

Pfizer (NYSE:PFE) reported a significant clinical milestone in its oncology pipeline today, announcing that the Phase 2 FOURLIGHT-1 study of atirmociclib met its primary endpoint.

Greenwich LifeSciences (NASDAQ:GLSI) released a preliminary update from its ongoing Phase III FLAMINGO-01 clinical trial, which evaluates the efficacy of GP2, an immunotherapy designed to prevent breast cancer recurrences.

Huya (NYSE:HUYA) reported unaudited financial results for the fourth quarter and full year ended December 31, 2025, revealing a strategic shift toward game-related services that has returned the company to top-line growth.

US President Donald Trump has intensified pressure on Federal Reserve Chair Jerome Powell to cut interest rates immediately, calling for an emergency move ahead of the central bank’s March decision.

Analysts have sharply raised their outlook on Circle, with new price targets implying as much as a 48% upside for the stablecoin issuer’s stock.

OpenSea has delayed the launch of its SEA token, pushing back plans from an originally scheduled March 30 rollout due to challenging market conditions.

Metaplanet has raised $255 million through a private placement and introduced new warrant structures to fund further Bitcoin acquisitions.